CD4 and HIV infectious disease: This dendrimer reduced the rates of HIV infection, not only by neutralizing the negative charges of the virus, but also by creating a competitive binding to viral targets (gp120 complex) and to cellular targets (CD4 receptor in areas relevant to CD4/gp120 and CCR5/gp120 or CXCR4/gp120 interactions).